149 related articles for article (PubMed ID: 19689287)
1. Preparation of hymenialdisine, analogues and their evaluation as kinase inhibitors.
Nguyen TN; Tepe JJ
Curr Med Chem; 2009; 16(24):3122-43. PubMed ID: 19689287
[TBL] [Abstract][Full Text] [Related]
2. Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
Zhang N; Zhong R; Yan H; Jiang Y
Chem Biol Drug Des; 2011 Mar; 77(3):199-205. PubMed ID: 21244636
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent.
Meijer L; Thunnissen AM; White AW; Garnier M; Nikolic M; Tsai LH; Walter J; Cleverley KE; Salinas PC; Wu YZ; Biernat J; Mandelkow EM; Kim SH; Pettit GR
Chem Biol; 2000 Jan; 7(1):51-63. PubMed ID: 10662688
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors.
Saleem RS; Lansdell TA; Tepe JJ
Bioorg Med Chem; 2012 Feb; 20(4):1475-81. PubMed ID: 22285028
[TBL] [Abstract][Full Text] [Related]
5. Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1).
Tasdemir D; Mallon R; Greenstein M; Feldberg LR; Kim SC; Collins K; Wojciechowicz D; Mangalindan GC; Concepción GP; Harper MK; Ireland CM
J Med Chem; 2002 Jan; 45(2):529-32. PubMed ID: 11784156
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytokine production by hymenialdisine derivatives.
Sharma V; Lansdell TA; Jin G; Tepe JJ
J Med Chem; 2004 Jul; 47(14):3700-3. PubMed ID: 15214798
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase.
Bagdanoff JT; Jain R; Han W; Zhu S; Madiera AM; Lee PS; Ma X; Poon D
Bioorg Med Chem Lett; 2015 Sep; 25(18):3788-92. PubMed ID: 26259804
[TBL] [Abstract][Full Text] [Related]
9. A new glycociamidine ring precursor: syntheses of (Z)-hymenialdisine, (Z)-2-debromohymenialdisine, and (+/-)-endo-2-debromohymenialdisine.
Papeo G; Posteri H; Borghi D; Varasi M
Org Lett; 2005 Dec; 7(25):5641-4. PubMed ID: 16321011
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine.
Sharma V; Tepe JJ
Bioorg Med Chem Lett; 2004 Aug; 14(16):4319-21. PubMed ID: 15261294
[TBL] [Abstract][Full Text] [Related]
11. Lamellarin alkaloids: Isolation, synthesis, and biological activity.
Fukuda T; Ishibashi F; Iwao M
Alkaloids Chem Biol; 2020; 83():1-112. PubMed ID: 32098648
[TBL] [Abstract][Full Text] [Related]
12. Bioactive pyrrole alkaloids isolated from the Red Sea: marine sponge Stylissa carteri.
Hamed ANE; Schmitz R; Bergermann A; Totzke F; Kubbutat M; Müller WEG; Youssef DTA; Bishr MM; Kamel MS; Edrada-Ebel R; Wätjen W; Proksch P
Z Naturforsch C J Biosci; 2018 Apr; 73(5-6):199-210. PubMed ID: 29353267
[TBL] [Abstract][Full Text] [Related]
13. Fused-azepinones: Emerging scaffolds of medicinal importance.
Akunuri R; Vadakattu M; Bujji S; Veerareddy V; Madhavi YV; Nanduri S
Eur J Med Chem; 2021 Aug; 220():113445. PubMed ID: 33901899
[TBL] [Abstract][Full Text] [Related]
14. Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
Brasca MG; Nesi M; Avanzi N; Ballinari D; Bandiera T; Bertrand J; Bindi S; Canevari G; Carenzi D; Casero D; Ceriani L; Ciomei M; Cirla A; Colombo M; Cribioli S; Cristiani C; Della Vedova F; Fachin G; Fasolini M; Felder ER; Galvani A; Isacchi A; Mirizzi D; Motto I; Panzeri A; Pesenti E; Vianello P; Gnocchi P; Donati D
Bioorg Med Chem; 2014 Sep; 22(17):4998-5012. PubMed ID: 25009002
[TBL] [Abstract][Full Text] [Related]
15. A one-pot synthesis and biological activity of ageladine A and analogues.
Shengule SR; Loa-Kum-Cheung WL; Parish CR; Blairvacq M; Meijer L; Nakao Y; Karuso P
J Med Chem; 2011 Apr; 54(7):2492-503. PubMed ID: 21413800
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues.
Parmentier JG; Portevin B; Golsteyn RM; Pierré A; Hickman J; Gloanec P; De Nanteuil G
Bioorg Med Chem Lett; 2009 Feb; 19(3):841-4. PubMed ID: 19111462
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics Mechanisms of the Inhibitory Effects of Abemaciclib, Hymenialdisine, and Indirubin on CDK-6.
Basati G; Saffari-Chaleshtori J; Abbaszadeh S; Asadi-Samani M; Ashrafi-Dehkordi K
Curr Drug Res Rev; 2019; 11(2):135-141. PubMed ID: 31875784
[TBL] [Abstract][Full Text] [Related]
18. From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase.
Juillet C; Ermolenko L; Boyarskaya D; Baratte B; Josselin B; Nedev H; Bach S; Iorga BI; Bignon J; Ruchaud S; Al-Mourabit A
J Med Chem; 2021 Jan; 64(2):1197-1219. PubMed ID: 33417773
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and target identification of hymenialdisine analogs.
Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS
Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors.
Musumeci F; Sanna M; Grossi G; Brullo C; Fallacara AL; Schenone S
Curr Med Chem; 2017; 24(19):2059-2085. PubMed ID: 28266267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
